![David Gordon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Gordon
Keine laufenden Positionen mehr
Profil
David Gordon served as the Chief Medical Officer at Aclaris Therapeutics, Inc. from 2018 to 2022.
Prior to that, he was the SVP and Head of Dermatology Research & Development at GSK Plc from 2016 to 2018.
Dr. Gordon earned a doctorate degree from the University of Aberdeen.
Ehemalige bekannte Positionen von David Gordon
| Unternehmen | Position | Ende |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.01.2022 |
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2018 |
Ausbildung von David Gordon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Aberdeen
 University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
